GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Panacea Biotec Ltd

Panacea Biotec receives Industrial Tribunal Awards on 23 workmen disputes since 2014

REGULATORY ▼ Concern Flagged MEDIUM RISK
📅 Filed on BSE: 10 Apr 2026, 04:21 PM IST  ·  BSE ID: 30afb79b-c27d-451c-9f9c-00bc6e8e39b5
View Original BSE Filing (PDF)
💡
In Simple Terms
A labour court ruled that the company wrongly transferred 23 workers and must pay them back wages and reinstate them with partial compensation.
🤖 AI Summary
  • Industrial Tribunal awarded relief to 23 workmen; set aside their transfers, granted full back wages
  • Awards dated March 19, 2026; disputes span from 2014 onwards under tribunal jurisdiction
  • Tribunal ordered wage revision for workmen and reinstatement with 50% back wages from termination
  • Company denies material adverse impact, plans High Court appeals challenging tribunal orders
🔢 Key Numbers — exact figures from BSE filing, not rounded
Workmen affected by transfer orders set aside
23
Dispute period covered
From 2014 onwards
Back wages on reinstatement
50% from date of termination
Date of tribunal Awards
March 19, 2026
Date of filing receipt
April 9, 2026
🏢 How This Affects the Company
💰
Financial Impact
Company has not quantified the financial liability from back wages, wage revision, and reinstatement obligations. Management asserts no material adverse impact, but exact cost remains undisclosed until appeals conclude.
⚙️
Operational Impact
The tribunal ordered reinstatement of workers (except those who settled disputes), directly affecting workforce composition and headcount in operations.
⚠️
Risk Impact
Labour dispute history from 2014 onwards is now formalized via tribunal Awards. Company faces execution risk on reinstatement and wage payment obligations pending High Court appeal outcomes.
👥 What This Means For Shareholders
✅
Action Required
No immediate action required. Monitor High Court appeal updates and subsequent disclosures on appeal outcomes and financial settlements.
👤
Who Is Affected
All equity shareholders bear the unquantified back wage, revision, and reinstatement cost liabilities if appeals fail. Impact on earnings and cash flow contingent on appeal outcome.
🔍
Management Signal
Management contests the tribunal Awards and asserts legal defensibility, indicating intent to minimize payout through appellate process rather than immediate settlement.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
High Court of Punjab and Haryana appeal filing — track case number and next hearing date
Tribunal Awards execution and reinstatement compliance status — watch for operational workforce changes
Follow-up BSE filing on financial quantification of back wages, revision, and settlement amounts
MEDIUM RISK 23 workmen reinstatement orders and unquantified back wage liabilities. Outcome contingent on High Court appeal success. Labour relations friction from 2014 disputes remains unresolved.
💡 Investor Takeaway
Industrial Tribunal awarded relief to 23 workmen spanning disputes from 2014 onwards: full back wages on transfers, wage revision, and reinstatement with 50% back wages. Company asserts no material adverse impact and is appealing to High Court. Exact financial liability remains unquantified.
⚖️ Strengths & Concerns

✅ Positives

  • Company asserts Awards are challengeable; pursuing High Court appeals to defend position and mitigate liability exposure.
  • Management states no material adverse financial, operational impact expected from these Awards based on legal opinion.

⚠️ Concerns

  • 23 workmen transfer orders set aside by tribunal; reinstatement obligations and back wage liabilities remain unquantified in filing.
  • Disputes span from 2014 onwards — 12-year history indicates sustained labour relations friction unresolved until tribunal intervention.
📅 Company Track Record
Panacea Biotec has disclosed multiple tax-related disputes recently: ₹10.23 Crore AY 2016-17 demand reversed to Nil (April 7, 2026); ₹45.71 Crore AY 2015-16 demand rectified to Nil with ₹32.27 Crore GST exposure remaining (April 7, 2026); ₹22.88 Crore GST demand with High Court interim stay (March 31, 2026); ₹9.38 Crore penalty upheld in appeal (March 27, 2026). Company faces multiple simultaneous regulatory exposures.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.